TrialHaematologica2024

Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study.

Fredrik H Schjesvold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.